Quality of life measurements: A soft outcome - Or is it?

Marlene H. Frost, Jeff A Sloan

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

In oncology research, quality of life (QOL) has been identified as the second most important outcome, with survival being the most important. The integration of QOL assessments into clinical practice and research presents some unique challenges. QOL outcomes are sometimes perceived to be soft, as opposed to the type of outcomes that provide hard end points or factual data and can be easily defined quantitatively. The softness of QOL outcomes relative to survival and tumor response is cited as a particular barrier to implementation and interpretation of results. This article reviews the importance of QOL to clinical practice, discusses the perceived softness of QOL, and compares the roles of symptoms and QOL scores as they relate to disease progression and tumor response. Providing sound QOL data to healthcare professionals and patients is essential to enable truly informed decision-making.

Original languageEnglish (US)
JournalAmerican Journal of Managed Care
Volume8
Issue number18 SUPPL.
StatePublished - Dec 2002

Fingerprint

quality of life
Quality of Life
Survival
Research
Disease Progression
Neoplasms
Decision Making
Disease
Delivery of Health Care
decision making
interpretation

ASJC Scopus subject areas

  • Medicine(all)
  • Nursing(all)
  • Health(social science)
  • Health Professions(all)

Cite this

Quality of life measurements : A soft outcome - Or is it? / Frost, Marlene H.; Sloan, Jeff A.

In: American Journal of Managed Care, Vol. 8, No. 18 SUPPL., 12.2002.

Research output: Contribution to journalArticle

@article{5ce12e9d665148d49a6ab640b707ea8b,
title = "Quality of life measurements: A soft outcome - Or is it?",
abstract = "In oncology research, quality of life (QOL) has been identified as the second most important outcome, with survival being the most important. The integration of QOL assessments into clinical practice and research presents some unique challenges. QOL outcomes are sometimes perceived to be soft, as opposed to the type of outcomes that provide hard end points or factual data and can be easily defined quantitatively. The softness of QOL outcomes relative to survival and tumor response is cited as a particular barrier to implementation and interpretation of results. This article reviews the importance of QOL to clinical practice, discusses the perceived softness of QOL, and compares the roles of symptoms and QOL scores as they relate to disease progression and tumor response. Providing sound QOL data to healthcare professionals and patients is essential to enable truly informed decision-making.",
author = "Frost, {Marlene H.} and Sloan, {Jeff A}",
year = "2002",
month = "12",
language = "English (US)",
volume = "8",
journal = "American Journal of Managed Care",
issn = "1088-0224",
publisher = "Ascend Media",
number = "18 SUPPL.",

}

TY - JOUR

T1 - Quality of life measurements

T2 - A soft outcome - Or is it?

AU - Frost, Marlene H.

AU - Sloan, Jeff A

PY - 2002/12

Y1 - 2002/12

N2 - In oncology research, quality of life (QOL) has been identified as the second most important outcome, with survival being the most important. The integration of QOL assessments into clinical practice and research presents some unique challenges. QOL outcomes are sometimes perceived to be soft, as opposed to the type of outcomes that provide hard end points or factual data and can be easily defined quantitatively. The softness of QOL outcomes relative to survival and tumor response is cited as a particular barrier to implementation and interpretation of results. This article reviews the importance of QOL to clinical practice, discusses the perceived softness of QOL, and compares the roles of symptoms and QOL scores as they relate to disease progression and tumor response. Providing sound QOL data to healthcare professionals and patients is essential to enable truly informed decision-making.

AB - In oncology research, quality of life (QOL) has been identified as the second most important outcome, with survival being the most important. The integration of QOL assessments into clinical practice and research presents some unique challenges. QOL outcomes are sometimes perceived to be soft, as opposed to the type of outcomes that provide hard end points or factual data and can be easily defined quantitatively. The softness of QOL outcomes relative to survival and tumor response is cited as a particular barrier to implementation and interpretation of results. This article reviews the importance of QOL to clinical practice, discusses the perceived softness of QOL, and compares the roles of symptoms and QOL scores as they relate to disease progression and tumor response. Providing sound QOL data to healthcare professionals and patients is essential to enable truly informed decision-making.

UR - http://www.scopus.com/inward/record.url?scp=0036951451&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036951451&partnerID=8YFLogxK

M3 - Article

C2 - 12512981

AN - SCOPUS:0036951451

VL - 8

JO - American Journal of Managed Care

JF - American Journal of Managed Care

SN - 1088-0224

IS - 18 SUPPL.

ER -